Donal O'Connor Net Worth & Insider Trades
Donal O'Connor - Director, Theravance Biopharma, Inc
What is Donal O'Connor's Net Worth?
The current estimated net worth of Theravance Biopharma, Inc's Director, Donal O'Connor, is estimated to be about $1.12M . Donal O'Connor owns about 27,571 units of Theravance Biopharma, Inc common stock. Recently at Theravance Biopharma, Inc, Donal O'Connor has sold an estimated value of $81.83K worth.
What is Donal O'Connor's Past Insider Trading?
Donal O'Connor's largest sale order was 4,000 units , worth over $81.83K on May 20, 2019. In total, Donal O'Connor has made about 1 transaction recently at Theravance Biopharma, Inc. Donal O'Connor usually trades in May, with the busiest year in 2019.
Donal OConnor
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Donal O'Connor's' Mailing Address?
- Mailing address is C/o Perrigo Company Plc 515 Eastern Avenue Allegan MI 49010 MI
Theravance Biopharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Rick E Winningham | 2020 | $1,014,455 | - | $579,646 | - | $579,646 | $6,045 | $6,577,746 |
| Rick E Winningham | 2019 | $983,710 | - | $473,906 | - | $473,906 | $5,496 | $5,932,411 |
| Rick E Winningham | 2018 | $956,600 | $74,767 | $690,154 | - | $690,154 | $5,000 | $2,522,841 |
| Andrew A. Hindman | 2020 | $551,608 | - | $265,278 | - | $265,278 | $5,920 | $2,097,950 |
| Andrew A. Hindman | 2019 | $315,000 | $175,000 | $216,000 | $2,204,956 | $216,000 | - | $3,757,956 |
| Brett Haumann | 2020 | $572,569 | - | $213,589 | - | $213,589 | $53,267 | $2,742,625 |
| Brett Haumann | 2019 | $543,047 | - | $170,000 | - | $170,000 | $42,382 | $2,464,280 |
| Brett Haumann | 2018 | $497,810 | $34,125 | $315,000 | - | $315,000 | $414,300 | $1,517,194 |
| Vijay Sabesan | 2020 | $407,677 | - | $760,326 | - | $760,326 | $6,541 | $3,077,744 |
| Bradford J. Shafer | 2020 | $556,321 | - | $264,999 | - | $264,999 | $6,045 | $2,730,565 |
| Bradford J. Shafer | 2019 | $537,403 | - | $215,611 | - | $215,611 | $6,983 | $2,468,848 |
| Bradford J. Shafer | 2018 | $518,080 | $33,770 | $311,726 | - | $311,726 | $5,000 | $1,124,537 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm
What are Theravance Biopharma, Inc's Past Insider Trades?
Theravance Biopharma, Inc's most recent insider trade came on December 16, 2022 by Rick Winningham who sold 59,000 units worth $559.5K . In the last 7 years, insiders at Theravance Biopharma, Inc have sold an estimated value of $149.71M and bought an estimated value of $26.3M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Bradford Shafer, EVP, Rick Winningham, CHIEF EXECUTIVE OFFICER, and Philip Worboys, SVP .
Theravance Biopharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||